U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from Gene

Items: 1 to 20 of 79

1.
TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells
Eliza E. Bitter, Jonathan Skidmore, Carolyn I. Allen, Rachel I. Erickson, Rachel M. Morris, Toni Mortimer, Audrey Meade, Rachel Brog, Tim Phares, Michelle Townsend, Brett E. Pickett, Kim L. O’Neill
PLoS One. 2023; 18(11): e0293128. Published online 2023 Nov 30. doi: 10.1371/journal.pone.0293128
PMCID:
PMC10688958
ArticlePDF–2.8M
2.
Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer
Bernhard Tribukait, Per-Olof Lundgren, Anders Kjellman, Ulf Norming, Claes R. Nyman, Kiran Jagarlmundi, Ove Gustafsson
Int J Mol Sci. 2023 Mar; 24(6): 5160. Published online 2023 Mar 8. doi: 10.3390/ijms24065160
PMCID:
PMC10049218
ArticlePDF–3.8M
3.
Evaluating Serum Thymidine Kinase 1 in Hormone Receptor Positive Metastatic Breast Cancer Patients Receiving First Line Endocrine Therapy in the SWOG S0226 Trial
Costanza Paoletti, William E. Barlow, Erin F. Cobain, Mattias Bergqvist, Rita S. Mehta, Julie R. Gralow, Gabriel N. Hortobagyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae
Clin Cancer Res. Author manuscript; available in PMC 2022 May 15.
Published in final edited form as: Clin Cancer Res. 2021 Nov 15; 27(22): 6115–6123. Published online 2021 Sep 14. doi: 10.1158/1078-0432.CCR-21-1562
PMCID:
PMC8595696
ArticlePDF–2.4M
4.
Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy
Luc Cabel, Dan Rosenblum, Florence Lerebours, Etienne Brain, Delphine Loirat, Mattias Bergqvist, Paul Cottu, Anne Donnadieu, Anne Bethune, Nicolas Kiavue, Manuel Rodrigues, Jean-Yves Pierga, Marie-Laure Tanguy, François-Clément Bidard
Breast Cancer Res. 2020; 22: 98. Published online 2020 Sep 14. doi: 10.1186/s13058-020-01334-2
PMCID:
PMC7489000
ArticlePDF–1.2M
5.
Potential through simplicity: thymidine kinase-1 as a biomarker for CDK4/6 inhibitors
Amelia McCartney, Luca Malorni
Br J Cancer. 2020 Jul 21; 123(2): 176–177. Published online 2020 May 8. doi: 10.1038/s41416-020-0858-y
PMCID:
PMC7374612
ArticlePDF–209K
6.
Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
Zhiwu Wang, Wei Zhang, Bingjie Huo, Liang Dong, Jing Zhang
Biosci Rep. 2020 Apr 30; 40(4): BSR20192813. Published online 2020 Apr 15. doi: 10.1042/BSR20192813
PMCID:
PMC7160240
ArticlePDF–444K
7.
Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion
Tian Tian, Jun Li, Wenjun Hu, Cuiling Sun, Jian Zhou
J Clin Lab Anal. 2019 Jul; 33(6): e22901. Published online 2019 Apr 15. doi: 10.1002/jcla.22901
PMCID:
PMC6642290
ArticlePDF–433K
8.
Cytotoxicity of trifluridine correlates with the thymidine kinase 1 expression level
Yuki Kataoka, Makoto Iimori, Shinichiro Niimi, Hiroshi Tsukihara, Takeshi Wakasa, Hiroshi Saeki, Eiji Oki, Yoshihiko Maehara, Hiroyuki Kitao
Sci Rep. 2019; 9: 7964. Published online 2019 May 28. doi: 10.1038/s41598-019-44399-6
PMCID:
PMC6538667
ArticlePDF–1.5M
9.
Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1‐TK1‐P21 axis
Xiaole Zhu, Chenyuan Shi, Yunpeng Peng, Lingdi Yin, Min Tu, Qiuyang Chen, Chaoqun Hou, Qiang Li, Yi Miao
Cell Prolif. 2018 Jun; 51(3): e12428. Published online 2017 Dec 20. doi: 10.1111/cpr.12428
PMCID:
PMC6528927
ArticlePDF–1.0M
10.
Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib
Nusayba Bagegni, Shana Thomas, Ning Liu, Jingqin Luo, Jeremy Hoog, Donald W. Northfelt, Matthew P. Goetz, Andres Forero, Mattias Bergqvist, Jakob Karen, Magnus Neumüller, Edward M. Suh, Zhanfang Guo, Kiran Vij, Souzan Sanati, Matthew Ellis, Cynthia X. Ma
Breast Cancer Res. 2017; 19: 123. Published online 2017 Nov 21. doi: 10.1186/s13058-017-0913-7
PMCID:
PMC5699111
ArticlePDF–1.0M
11.
A clinical evaluation of the TK 210 ELISA in sera from breast cancer patients demonstrates high sensitivity and specificity in all stages of disease
J. Kiran Kumar, A. C. Aronsson, G. Pilko, M. Zupan, K. Kumer, T. Fabjan, J. Osredkar, S. Eriksson
Tumour Biol. 2016 Sep; 37(9): 11937–11945. Published online 2016 Apr 14. doi: 10.1007/s13277-016-5024-z
PMCID:
PMC5080325
ArticlePDF–728K
12.
Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker
Kiran Kumar Jagarlamudi, Lars Olof Hansson, Staffan Eriksson
BMC Cancer. 2015; 15: 66. Published online 2015 Feb 18. doi: 10.1186/s12885-015-1073-8
PMCID:
PMC4336758
ArticlePDF–2.1M
13.
Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix
Gang Chen, Cheng He, Ling Li, An Lin, Xiongwei Zheng, Ellen He, Sven Skog
BMC Cancer. 2013; 13: 249. Published online 2013 May 21. doi: 10.1186/1471-2407-13-249
PMCID:
PMC3665464
ArticlePDF–881K
14.
Regulation and Functional Contribution of Thymidine Kinase 1 in Repair of DNA Damage
Yen-Ling Chen, Staffan Eriksson, Zee-Fen Chang
J Biol Chem. 2010 Aug 27; 285(35): 27327–27335. Published online 2010 Jun 16. doi: 10.1074/jbc.M110.137042
PMCID:
PMC2930731
ArticlePDF–1.6M
15.
Nonpolar Nucleoside Mimics as Active Substrates for Human Thymidine Kinases
Sarah K. Jarchow-Choy, Elena Sjuvarsson, Herman O. Sintim, Staffan Eriksson, Eric T. Kool
J Am Chem Soc. Author manuscript; available in PMC 2010 Jun 24.
Published in final edited form as: J Am Chem Soc. 2009 Apr 22; 131(15): 5488–5494. doi: 10.1021/ja808244t
PMCID:
PMC2891540
ArticlePDF–733K
16.
Elevated levels of thymidine kinase 1 peptide in serum from patients with breast cancer
Lena Carlsson, Anders Larsson, Henrik Lindman
Ups J Med Sci. 2009 Jun; 114(2): 116–120. Published online 2009 Apr 24. doi: 10.1080/03009730802688835
PMCID:
PMC2852757
ArticlePDF–66K
17.
Mass action models versus the Hill model: An analysis of tetrameric human thymidine kinase 1 positive cooperativity
Tomas Radivoyevitch
Biol Direct. 2009; 4: 49. Published online 2009 Dec 9. doi: 10.1186/1745-6150-4-49
PMCID:
PMC2799445
ArticlePDF–1.1M
18.
Structures of thymidine kinase 1 of human and mycoplasmic origin
Martin Welin, Urszula Kosinska, Nils-Egil Mikkelsen, Cecilia Carnrot, Chunying Zhu, Liya Wang, Staffan Eriksson, Birgitte Munch-Petersen, Hans Eklund
Proc Natl Acad Sci U S A. 2004 Dec 28; 101(52): 17970–17975. Published online 2004 Dec 20. doi: 10.1073/pnas.0406332102
PMCID:
PMC539776
ArticlePDF–701K
19.
Human thymidine kinase gene: molecular cloning and nucleotide sequence of a cDNA expressible in mammalian cells.
H D Bradshaw, Jr, P L Deininger
Mol Cell Biol. 1984 Nov; 4(11): 2316–2320. doi: 10.1128/mcb.4.11.2316
PMCID:
PMC369060
SummaryPage BrowsePDF–1.1M
20.
Genetic analysis of the human thymidine kinase gene promoter.
J A Kreidberg, T J Kelly
Mol Cell Biol. 1986 Aug; 6(8): 2903–2909. doi: 10.1128/mcb.6.8.2903
PMCID:
PMC367858
SummaryPage BrowsePDF–1.2M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center